Trials / Terminated
TerminatedNCT01786447
Biomarkers of Brain Injury: Magnitude and Outcome of Mild and Moderate TBI
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 111 (actual)
- Sponsor
- Banyan Biomarkers, Inc · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine if specific brain injury biomarkers have utility as blood-based traumatic brain injury (TBI) diagnostic and monitoring tools. This will be accomplished by examining the relationships between potential serum-based TBI biomarkers and clinical measures of injury severity, occurrence of complications, and outcome, in subjects with mild or moderate TBI as well as in orthopedic control subjects.
Conditions
Timeline
- Start date
- 2010-04-01
- Primary completion
- 2011-03-01
- Completion
- 2011-03-01
- First posted
- 2013-02-08
- Last updated
- 2013-02-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01786447. Inclusion in this directory is not an endorsement.